Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

13 Oct 2021 07:00

RNS Number : 8661O
Centaur Media PLC
13 October 2021
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

 

13 October 2021

Centaur Media Plc

("Centaur" or the "Company")

Trading Update & Capital Markets Day

Centaur Media Plc, an international provider of business information, training and specialist consultancy, is pleased to announce an update on trading for the period ended 30 September 2021 and its outlook for the full year. The Company is also hosting its 2021 Capital Markets Day today.

 

Trading Update

 

Since the publication of the Company's Interim Results on 21 July 2021, the Board is pleased to announce that Centaur has continued to experience strong trading conditions enabling it to grow its revenues and adjusted1 EBITDA across both Xeim and The Lawyer.

 

Centaur's Brands continue to perform in line with its Margin Acceleration Plan (MAP23) objectives, notably:

 

•

Econsultancy is seeing subscriptions outperform management expectations, mainly through a sustained level of new business wins and demand for its blended learning proposition. Delivery of its training offering is on track.

•

The Marketing Week Mini MBA had another period of high double-digit growth driven by increased delegate numbers and price increases.

•

Influencer Intelligence is recovering as its new business and renewal rates are starting to rise following the significant impact of Covid on its smaller PR and fashion customers.

•

The Lawyer is ahead of target on corporate renewal rates, while billings are on track for its new Signal product, a subscription service offering in-depth strategic insight and benchmarking of markets, clients and competitors. Recruitment advertising has shown a strong recovery since 2020.

 

Next week, Centaur will be hosting the pinnacle in its events calendar, the Festival of Marketing: The Year Ahead. The four-day virtual event with live Q&As and video-on-demand will feature over 80 speakers, including the senior marketing leaders of several high profile brands such as Mastercard, Tesco, Coca-Cola, Diageo and Virgin, who will be joined by leading marketing academics Byron Sharp and Mark Ritson, as well as John Cleese, Eddie Izzard and Richard Curtis. The Lawyer is also hosting a number of events in Q4 including next week's hybrid In-House Counsel as Business Partner and next month's The Lawyer Awards.

 

Centaur's net cash balance stood at ÂŁ12.4m as at 30 September 2021 (ÂŁ11.9m as at 30 June 2021).

 

2021 Full Year Outlook

 

The Board expects full-year revenues to exceed ÂŁ37m, a 15% year-on-year increase and at the top end of market expectations. Margins in H2 2021 continue to improve, with adjusted1 EBITDA margin for FY 2021 expected to be approximately 15%.

 

Xeim, our business unit serving the marketing sector, is expected to report a year-on-year underlying revenue increase of at least 17% with The Lawyer expecting to report an underlying revenue increase of at least 7%.

 

The Board remains confident in the successful delivery of Centaur's revenue and EBITDA margin objectives as set out under MAP23.

 

Capital Markets Day

 

Centaur will today hold a Capital Markets Day for institutional investors and analysts. The event will be hosted by Swag Mukerji, CEO, and Simon Longfield, CFO, together with a number of the senior management team from across the Company.

 

The Capital Markets Day will cover Centaur's strategic progress, while providing further detail on its Flagship 4 and Core Brands and outlining the role of these brands within the Company's MAP23 strategy.

 

The presentations will commence at 10:00 BST. A recording will subsequently be made available on the Company's website.

 

No further trading information will be disclosed during the event.

 

1 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation on a post-IFRS 16 basis. Adjusted results exclude adjusting items, such as exceptional items, as detailed in note 4 of the Interim Report for the period ended 30 June 2021.

 

Enquiries

Centaur Media Plc

020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

Teneo

Zoë Watt / Matthew Thomlinson

07713 157561 / 07785 528363

Note to editors

Centaur is an international provider of business information, training and specialist consultancy that inspires and enables people to excel at what they do, raising the standard for insight, interaction and impact.  Leading brands include The Lawyer, Econsultancy, Influencer Intelligence, MW Mini MBA, Marketing Week, Festival of Marketing, Creative Review, Fashion & Beauty Monitor, Oystercatchers and Really B2B.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUAKRANURAAA
Date   Source Headline
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company
1st Nov 202110:33 amRNSHolding(s) in Company
20th Oct 202111:54 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSTrading Update
6th Oct 20219:30 amRNSHolding(s) in Company
21st Sep 202110:31 amRNSDirector/PDMR Shareholding
7th Sep 202112:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.